B. 1. Wanless, I. R. Mawdsley, C. Adams, and R. , On the pathogenesis of focal nodular hyperplasia of the liver, Hepatology, vol.396, issue.6, pp.1194-1200, 1985.
DOI : 10.2214/ajr.134.3.594

V. Paradis, A. Laurent, J. F. Flejou, M. Vidaud, and P. Bedossa, Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation, Hepatology, vol.26, issue.4, pp.891-895, 1997.
DOI : 10.1002/hep.510260414

P. J. Karhunen, Benign hepatic tumours and tumour like conditions in men., Journal of Clinical Pathology, vol.39, issue.2
DOI : 10.1136/jcp.39.2.183

B. N. Nguyen, J. F. Fléjou, B. Terris, J. Belghiti, and C. Degott, Focal Nodular Hyperplasia of the Liver, The American Journal of Surgical Pathology, vol.23, issue.12, pp.1441-1454, 1999.
DOI : 10.1097/00000478-199912000-00001

V. Vilgrain, Prevalence of Hepatic Hemangioma in Patients with Focal Nodular Hyperplasia: MR Imaging Analysis, Radiology, vol.229, issue.1, pp.75-79, 2003.
DOI : 10.1148/radiol.2291021284

S. Rebouissou, P. Bioulac-sage, and J. Zucman-rossi, Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma, Journal of Hepatology, vol.48, issue.1, pp.163-170, 2008.
DOI : 10.1016/j.jhep.2007.10.003

URL : https://hal.archives-ouvertes.fr/inserm-00187575

I. R. Wanless, Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.2, pp.456-462, 1989.

D. Mathieu, Oral contraceptive use and focal nodular hyperplasia of the liver, Gastroenterology, vol.118, issue.3, pp.560-564, 2000.
DOI : 10.1016/S0016-5085(00)70262-9

D. Cherqui, Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlations, Hepatology, vol.220, issue.6, pp.1674-1681, 1995.
DOI : 10.1148/radiology.178.1.1984314

D. 'halluin and V. , Natural history of focal nodular hyperplasia

P. Bioulac-sage, Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver, Gastroenterology, vol.128, issue.5, pp.1211-1218, 2005.
DOI : 10.1053/j.gastro.2005.02.004

V. Paradis, Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma, Gastroenterology, vol.126, issue.5, pp.1323-1329, 2004.
DOI : 10.1053/j.gastro.2004.02.005

H. Laumonier, Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity, Case Reports, vol.2010, issue.nov30 1, 2010.
DOI : 10.1136/bcr.09.2010.3311

P. Bioulac-sage, Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma Subtypes, The American Journal of Surgical Pathology, vol.36, issue.11, pp.1691-1699, 2012.
DOI : 10.1097/PAS.0b013e3182653ece

URL : https://hal.archives-ouvertes.fr/hal-00855767

M. D. Mcinnes, R. M. Hibbert, J. R. Inácio, and N. Schieda, Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid???enhanced MR Imaging???A Systematic Review, Radiology, vol.277, issue.2, pp.413-423, 2015.
DOI : 10.1148/radiol.2015142986

S. M. Hussain, Focal Nodular Hyperplasia: Findings at State-of-the-Art MR Imaging, US, CT, and Pathologic Analysis, RadioGraphics, vol.24, issue.1, pp.3-17, 2004.
DOI : 10.1148/rg.241035050

M. D. Burgio, M. Ronot, G. Salvaggio, V. Vilgrain, and G. Brancatelli, Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy

. Semin, 18. EASL Clinical Practice Guidelines on the management of benign liver tumours, Ultrasound. CT MR, vol.37, pp.511-524, 2016.

Y. Kuo, Natural course of hepatic focal nodular hyperplasia: A long-term follow-up study with sonography, Journal of Clinical Ultrasound, vol.38, issue.3, pp.132-137, 2009.
DOI : 10.3748/wjg.v12.i40.6567

D. Stasi and M. , Natural history of focal nodular hyperplasia of the liver: An ultrasound study, Journal of Clinical Ultrasound, vol.137, issue.7, pp.345-350, 1996.
DOI : 10.7326/0003-4819-85-2-203

J. A. Halankar, T. K. Kim, H. Jang, K. Khalili, and H. A. Masoom, Understanding the natural history of focal nodular hyperplasia in the liver with MRI, Indian Journal of Radiology and Imaging, vol.22, issue.2
DOI : 10.4103/0971-3026.101084

A. Crombe, N. Aberti, P. Balageas, and N. Frulio, ??volution fibreuse d???une hyperplasie nodulaire focale??: ?? propos d???un cas, Journal de Radiologie Diagnostique et Interventionnelle, vol.96, pp.76-78, 2015.
DOI : 10.1016/j.jradio.2014.06.004

M. Kinoshita, Ruptured focal nodular hyperplasia observed during follow-up: a case report, Surgical Case Reports, vol.36, issue.5, p.44, 2017.
DOI : 10.1007/s00268-012-1734-6

J. A. Marrero, J. Ahn, R. Reddy, and K. , ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions, The American Journal of Gastroenterology, vol.9, issue.9, pp.1328-1347, 2014.
DOI : 10.1016/j.ijid.2004.08.001

A. P. Navarro, D. Gomez, C. M. Lamb, A. Brooks, and I. C. Cameron, Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection, HPB, vol.16, issue.6, pp.503-511, 2014.
DOI : 10.1111/hpb.12169

M. Khanna, Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma, Insights into Imaging, vol.187, issue.2, pp.347-362, 2015.
DOI : 10.1016/j.amjsurg.2003.11.016

J. K. Baum, J. J. Bookstein, F. Holtz, and E. W. Klein, Possible association between benign hepatomas and oral contraceptives, Lancet Lond. Engl, vol.2, pp.926-929, 1973.

J. B. Rooks, Epidemiology of Hepatocellular Adenoma, JAMA, vol.242, issue.7, pp.644-648, 1979.
DOI : 10.1001/jama.1979.03300070040020

J. Nault, P. Bioulac-sage, and J. Zucman-rossi, Hepatocellular Benign Tumors???From Molecular Classification to Personalized Clinical Care, Gastroenterology, vol.144, issue.5, pp.888-902, 2013.
DOI : 10.1053/j.gastro.2013.02.032

O. Bluteau, Bi-allelic inactivation of TCF1 in hepatic adenomas, Nature Genetics, vol.120, issue.2
DOI : 10.1038/35057062

K. Yamagata, Mutations in the hepatocyte nuclear factor-1?? gene in maturity-onset diabetes of the young (MODY3), Nature, vol.384, issue.6608, pp.455-458, 1996.
DOI : 10.1038/384455a0

E. Jeannot, Spectrum of HNF1A Somatic Mutations in Hepatocellular Adenoma Differs From That in Patients With MODY3 and Suggests Genotoxic Damage, Diabetes, vol.59, issue.7, pp.1836-1844, 2010.
DOI : 10.2337/db09-1819

Y. Bacq, Familia liver adenomatosis associated with hepatocyte nuclear factor 1?? inactivation1 1The authors thank Leigh Pascoe for critical reading of the manuscript, H??l??ne Blanch?? and Hung Bui of the CEPH/Fondation Jean Dausset for technical help in sequencing, and Drs. A. Saillant, E. Akodjenou, and E. Urvoas (Pediatric and Radiology Units, H??pitaux de Chartres, France) for referring patient B1 to E.J. and for performing liver ultrasound screening in family B., Gastroenterology, vol.125, issue.5, pp.1470-1475, 2003.
DOI : 10.1016/j.gastro.2003.07.012

P. Bioulac-sage, Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry, Hepatology, vol.25, issue.3, pp.740-748, 2007.
DOI : 10.7326/0003-4819-105-4-547

H. Laumonier, Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification, Hepatology, vol.241, issue.3, pp.808-818, 2008.
DOI : 10.3748/wjg.v13.i19.2649

S. P. Bise, C. Sempoux, and C. Balabaud, Progress and limits of MRI in hepatocellular adenoma phenotype identification; management implications ; sous la direction de Nora Frulio ? Bibliothèque des Sciences du Vivant et de la Santé -Université de Bordeaux (CMT 2016-3041) Hepatocellular adenoma: Classification, variants and clinical relevance, Semin. Diagn. Pathol, vol.34, pp.112-125, 2017.

M. Bieze, Diagnostic Accuracy of MRI in Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia: Prospective Study of the Additional Value of Gadoxetate Disodium, American Journal of Roentgenology, vol.199, issue.1, pp.26-34, 2012.
DOI : 10.2214/AJR.11.7750

A. Laurent, European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group, HPB, vol.18, issue.9, pp.748-755, 2016.
DOI : 10.1016/j.hpb.2016.06.011

S. Dokmak, A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas, Gastroenterology, vol.137, issue.5, pp.1698-1705, 2009.
DOI : 10.1053/j.gastro.2009.07.061

P. Bioulac-sage, Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience, Hepatology, vol.48, issue.4 Suppl, pp.481-489, 2009.
DOI : 10.1002/hep.22417

J. H. Stoot, R. J. Coelen, M. C. Jong, and C. H. Dejong, Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases, HPB, vol.12, issue.8, pp.509-522, 2010.
DOI : 10.1111/j.1477-2574.2010.00222.x

L. Bossen, H. Grønbaek, P. Lykke-eriksen, and P. Jepsen, Men with biopsyconfirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study, Liver Int. Off. J. Int. Assoc. Study Liver, vol.37, pp.1042-1046, 2017.

M. C. Wong, International incidence and mortality trends of liver cancer: a global profile, Scientific Reports, vol.136, p.45846, 2017.
DOI : 10.1002/ijc.29210

C. Schraml, Imaging of HCC???Current State of the Art, Diagnostics, vol.16, issue.4, pp.513-545, 2015.
DOI : 10.1097/MCG.0b013e31827f0d3d

H. B. El-serag and . Hepatocellular-carcinoma, Hepatocellular Carcinoma, New England Journal of Medicine, vol.365, issue.12, pp.1118-1127, 2011.
DOI : 10.1056/NEJMra1001683

N. Leone, N. Voirin, and L. Roche, Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015 49. van Meer, S. et al. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands, Eur. J. Gastroenterol. Hepatol, vol.62, issue.28, pp.352-359, 2015.

M. Blachier, H. Leleu, M. Peck-radosavljevic, D. Valla, and F. Roudot-thoraval, The burden of liver disease in Europe: A review of available epidemiological data, Journal of Hepatology, vol.58, issue.3, pp.593-608, 2013.
DOI : 10.1016/j.jhep.2012.12.005

G. Cholankeril, R. Patel, S. Khurana, and S. K. Satapathy, Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management, World Journal of Hepatology, vol.9, issue.11, pp.533-543, 2017.
DOI : 10.1007/s12072-015-9679-0

D. Ganeshan, Imaging Features of Fibrolamellar Hepatocellular Carcinoma, American Journal of Roentgenology, vol.202, issue.3, pp.544-552, 2014.
DOI : 10.2214/AJR.13.11117

K. J. Lafaro and T. M. Pawlik, Fibrolamellar hepatocellular carcinoma: current clinical perspectives, J. Hepatocell. Carcinoma, vol.2, pp.151-157, 2015.

J. Bruix, Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference, Journal of Hepatology, vol.35, issue.3, pp.421-430, 2001.
DOI : 10.1016/S0168-8278(01)00130-1

R. K. American-college-of-radiology-do, A. Mcerlean, C. S. Ang, R. P. Dematteo, and G. K. Abou-alfa, Liver imaging reporting and data system (LI- RADS) version 2014. disponible sur https://nrdr.acr.org/lirads/ 57 CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients, Br. J. Radiol, vol.87, 2014.

. Cholangiocarcinoma, Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center, Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver, vol.48, pp.231-241, 2016.

J. Bridgewater, Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.60, issue.6, pp.1268-1289, 2014.
DOI : 10.1016/j.jhep.2014.01.021

S. M. Weber, Intrahepatic Cholangiocarcinoma: expert consensus statement, HPB, vol.17, issue.8, pp.669-680, 2015.
DOI : 10.1111/hpb.12441

M. Ciresa, Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features, Eur. Rev. Med. Pharmacol

B. Huang, Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging, Radiology, vol.281, issue.1, pp.150-157, 2016.
DOI : 10.1148/radiol.2016151205

C. Grieser, Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience, European Radiology, vol.53, issue.6, pp.1339-1348, 2014.
DOI : 10.1002/hep.24147

A. S. Purysko, Characteristics and Distinguishing Features of Hepatocellular Adenoma and Focal Nodular Hyperplasia on Gadoxetate Disodium???Enhanced MRI, American Journal of Roentgenology, vol.198, issue.1, pp.115-123, 2012.
DOI : 10.2214/AJR.11.6836

J. H. Min, Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum, European Journal of Radiology, vol.92, pp.1-10, 2017.
DOI : 10.1016/j.ejrad.2017.04.008

S. H. Choi, Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid???enhanced MR Imaging and Dynamic CT, Radiology, vol.282, issue.3, 2016.
DOI : 10.1148/radiol.2016160639

R. Kim, Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging, European Radiology, vol.38, issue.6
DOI : 10.1016/j.clinimag.2013.12.022

L. Castéra, I. Nègre, K. Samii, and C. Buffet, Pain experienced during percutaneous liver biopsy, Hepatology, vol.352, issue.Suppl, pp.1529-1530, 1999.
DOI : 10.1016/S0140-6736(98)07124-4

H. Laumonier, Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification, Hepatology, vol.241, issue.3, pp.808-818, 2008.
DOI : 10.3748/wjg.v13.i19.2649

M. Ronot, Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification, Hepatology, vol.241, issue.4, pp.1182-1191, 2011.
DOI : 10.1148/radiol.2412051243

F. Donati, Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics, Magnetic Resonance Imaging, vol.31, issue.1, pp.10-16, 2013.
DOI : 10.1016/j.mri.2012.06.031

D. Kehagias, Focal nodular hyperplasia: imaging findings, European Radiology, vol.11, issue.2, pp.202-212, 2001.
DOI : 10.1007/s003300000575

S. M. Hussain, Focal Nodular Hyperplasia: Findings at State-of-the-Art MR Imaging, US, CT, and Pathologic Analysis, RadioGraphics, vol.24, issue.1, pp.3-17, 2004.
DOI : 10.1148/rg.241035050

S. M. Hussain, Benign versus Malignant Hepatic Nodules: MR Imaging Findings with Pathologic Correlation, RadioGraphics, vol.22, issue.5, pp.1023-1036, 2002.
DOI : 10.1148/radiographics.22.5.g02se061023

H. J. Park, Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis, European Radiology, vol.21, issue.Suppl 6, pp.3102-3111, 2016.
DOI : 10.5152/dir.2014.13013

P. Bioulac-sage, Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience, Hepatology, vol.48, issue.4 Suppl, pp.481-489, 2009.
DOI : 10.1002/hep.22417

P. Bioulac-sage, Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry, Hepatology, vol.25, issue.3, pp.740-748, 2007.
DOI : 10.7326/0003-4819-105-4-547

P. Bioulac-sage, Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update, Journal of Hepatology, vol.46, issue.3, pp.521-527, 2007.
DOI : 10.1016/j.jhep.2006.12.007

E. R. Delong, D. M. Delong, and D. L. Clarke-pearson, Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach, Biometrics, vol.44, issue.3, pp.837-845, 1988.
DOI : 10.2307/2531595

H. Laumonier, Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity, Case Reports, vol.2010, issue.nov30 1, 2010.
DOI : 10.1136/bcr.09.2010.3311

N. Alberti, Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation, Diagnostic and Interventional Imaging, vol.95, issue.1, pp.77-83, 2014.
DOI : 10.1016/j.diii.2013.09.002

T. Denecke, Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI, European Radiology, vol.46, issue.8, pp.1769-1775, 2012.
DOI : 10.1002/hep.21743

L. Grazioli, G. Morana, M. A. Kirchin, and G. Schneider, Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine???enhanced MR Imaging: Prospective Study, Radiology, vol.236, issue.1, pp.166-177, 2005.
DOI : 10.1148/radiol.2361040338

L. Grazioli, Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid???enhanced MR Imaging in Differential Diagnosis, Radiology, vol.262, issue.2, pp.520-529, 2012.
DOI : 10.1148/radiol.11101742

M. Roux, Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI, Journal of Magnetic Resonance Imaging, vol.38, issue.5, 2015.
DOI : 10.1016/j.clinre.2014.01.014

O. F. Donati, MRI for characterization of primary tumors in the noncirrhotic liver: added value of Gd-EOB-DTPA enhanced hepatospecific phase, Eur. J

J. W. Kim, The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization, European Journal of Radiology, vol.89, pp.169-176, 2017.
DOI : 10.1016/j.ejrad.2017.02.004

A. Kitao, Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of ??-catenin and hepatocyte nuclear factor 4?? in hepatocellular carcinoma, Hepatology Research, vol.279, issue.Suppl 19, pp.10-1111
DOI : 10.1074/jbc.M311015200

S. Agarwal, Inflammatory Hepatocellular Adenomas Can Mimic Focal Nodular Hyperplasia on Gadoxetic Acid???Enhanced MRI, American Journal of Roentgenology, vol.203, issue.4, pp.408-414, 2014.
DOI : 10.2214/AJR.13.12251

N. Yoneda, Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8, Japanese Journal of Radiology, vol.234, issue.2, pp.777-782, 2012.
DOI : 10.1002/path.1852